Cue Biopharma, Inc. (CUE) financial statements (2020 and earlier)

Company profile

Business Address 21 ERIE STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:5939
Cash and cash equivalents4421
Short-term investments1518
Other undisclosed cash, cash equivalents, and short-term investments 0
Restricted cash and investments 0
Receivables1 
Other undisclosed current assets11
Total current assets:6141
Noncurrent Assets
Operating lease, right-of-use asset5
Property, plant and equipment23
Deposits noncurrent assets31
Restricted cash and investments00
Other noncurrent assets11
Total noncurrent assets:115
TOTAL ASSETS:7245
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34
Accounts payable12
Accrued liabilities22
Debt4 
Deferred rent credit 0
Other undisclosed current liabilities42
Total current liabilities:126
Noncurrent Liabilities
Long-term debt and lease obligation1 
Operating lease, liability1
Other undisclosed noncurrent liabilities45
Total noncurrent liabilities:55
Total liabilities:1711
Stockholders' equity
Stockholders' equity attributable to parent5534
Common stock00
Additional paid in capital163106
Accumulated other comprehensive loss(0)(0)
Accumulated deficit(109)(72)
Total stockholders' equity:5534
TOTAL LIABILITIES AND EQUITY:7245

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Gross profit:31
Operating expenses(40)(40)
Operating loss:(37)(39)
Nonoperating income01
Other nonoperating income00
Loss from continuing operations before income taxes:(36)(38)
Income tax expense(0)(1)
Net loss available to common stockholders, diluted:(37)(39)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(37)(39)
Other comprehensive income0 
Comprehensive loss:(37)(39)
Other undisclosed comprehensive loss, net of tax, attributable to parent (0)
Comprehensive loss, net of tax, attributable to parent:(37)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: